Sigma Attracts New Bidder for Generic Drugs Business, Morning Herald Says
By Jacob Greber -
2010-08-01T22:16:41Z
Sigma Pharmaceuticals Ltd. may have attracted a new bidder for its A$600 million generics business, with U.S.-based Watson Pharmaceuticals considering an offer for the division, the Sydney Morning Herald said. While Watson hasn’t made a formal offer, it has looked at the business, the newspaper reported, without saying where it got the information.
To contact the reporter on this story: Jacob Greber in Sydney at jgreber@bloomberg.net
More News:
Sponsored Links
Rate this Page